share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  09/17 06:05
Moomoo AI 已提取核心訊息
Conduit Pharmaceuticals, known in the stock market as CDT.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC). On September 10, 2024, at 5:00 P.M., the SEC granted effectiveness to the company's Form F-1 filing. This development is a critical step for Conduit Pharmaceuticals, which operates under the legal name Genius Group Ltd, as indicated by its CIK number 0001847806. The effectiveness of the Form F-1, associated with file number 333-279795, marks a pivotal moment for the company's future financial activities.
Conduit Pharmaceuticals, known in the stock market as CDT.US, has achieved a significant milestone with the United States Securities and Exchange Commission (SEC). On September 10, 2024, at 5:00 P.M., the SEC granted effectiveness to the company's Form F-1 filing. This development is a critical step for Conduit Pharmaceuticals, which operates under the legal name Genius Group Ltd, as indicated by its CIK number 0001847806. The effectiveness of the Form F-1, associated with file number 333-279795, marks a pivotal moment for the company's future financial activities.
Conduit Pharmaceuticals(股票代號:CDt.US)已與美國證券交易委員會(SEC)取得重要的里程碑。2024年9月10日下午5點,SEC對該公司的F-1表格提交備案文件授予了效力。這一進展對於執法名爲Genius Group Ltd的Conduit Pharmaceuticals(CIK號碼:0001847806)來說是一個至關重要的步驟。與文件號333-279795相關的F-1表格的效力標誌着該公司未來金融活動的一個關鍵時刻。
Conduit Pharmaceuticals(股票代號:CDt.US)已與美國證券交易委員會(SEC)取得重要的里程碑。2024年9月10日下午5點,SEC對該公司的F-1表格提交備案文件授予了效力。這一進展對於執法名爲Genius Group Ltd的Conduit Pharmaceuticals(CIK號碼:0001847806)來說是一個至關重要的步驟。與文件號333-279795相關的F-1表格的效力標誌着該公司未來金融活動的一個關鍵時刻。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息